Skip to content

Healthcare Decisions Post-Testing, Risk-reducing and Preventative Strategies Using LYNCH Genetic Testing Reducing, and Preventative Strategies Using LYNCH Genetic Testing

Medical Provider Experience Assessment Healthcare Decisions Post-Testing, Risk-Reducing, and Preventative Strategies Using LYNCH Genetic Testing

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03322176
Enrollment
200
Registered
2017-10-26
Start date
2017-10-17
Completion date
2020-11-01
Last updated
2019-01-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colon Cancer, Endometrial Cancer

Brief summary

Increase surveillance for LYNCH Syndrome

Detailed description

The purpose of this minimal risk, observational survey is to increase surveillance for Lynch Syndrome (hereditary non-polyposis colon cancer), Colorectal, and Endometrial cancer, also to determine targeted risk-reducing and preventative strategies.

Interventions

OTHERGenetic testing

LYNCH genetic testing

Sponsors

PAS Research Services
CollaboratorOTHER
Data Collection Analysis Business Management
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 64 Years
Healthy volunteers
Yes

Inclusion criteria

* Must be a Medical Practitioner * Medical Doctor (MD) * Doctor of Osteopathic (DO) * Physician Assistant (PA) * Advanced Practice Registered Nurse (APRN) * Nurse Practitioner (NP) * Must have a current standard operating procedure that includes obtaining/reviewing medical history and family medical history.

Exclusion criteria

* Government-funded insurance data cannot be included in the study.

Design outcomes

Primary

MeasureTime frameDescription
Provider Structures and Processes36 monthsPlan of Care Changes due to LYNCH genetic testing. Provider based observational survey system on the health and well-being of patients and populations

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026